nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP19A1—Betamethasone—ankylosing spondylitis	0.246	0.298	CbGbCtD
Letrozole—CYP2A6—Prednisolone—ankylosing spondylitis	0.154	0.186	CbGbCtD
Letrozole—CYP19A1—Dexamethasone—ankylosing spondylitis	0.143	0.173	CbGbCtD
Letrozole—CYP2A6—Dexamethasone—ankylosing spondylitis	0.0907	0.11	CbGbCtD
Letrozole—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.048	0.058	CbGbCtD
Letrozole—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0364	0.0439	CbGbCtD
Letrozole—CYP3A4—Betamethasone—ankylosing spondylitis	0.0312	0.0377	CbGbCtD
Letrozole—CYP3A4—Prednisolone—ankylosing spondylitis	0.0308	0.0372	CbGbCtD
Letrozole—CYP3A4—Prednisone—ankylosing spondylitis	0.0291	0.0351	CbGbCtD
Letrozole—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0181	0.0219	CbGbCtD
Letrozole—Hypertension—Triamcinolone—ankylosing spondylitis	0.000293	0.0017	CcSEcCtD
Letrozole—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000292	0.00169	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000291	0.00169	CcSEcCtD
Letrozole—Myalgia—Triamcinolone—ankylosing spondylitis	0.000289	0.00167	CcSEcCtD
Letrozole—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000288	0.00167	CcSEcCtD
Letrozole—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000288	0.00167	CcSEcCtD
Letrozole—Eye disorder—Prednisone—ankylosing spondylitis	0.000288	0.00167	CcSEcCtD
Letrozole—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000287	0.00166	CcSEcCtD
Letrozole—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000287	0.00166	CcSEcCtD
Letrozole—Infestation—Methotrexate—ankylosing spondylitis	0.000287	0.00166	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000286	0.00166	CcSEcCtD
Letrozole—Depression—Methotrexate—ankylosing spondylitis	0.000286	0.00166	CcSEcCtD
Letrozole—Flushing—Prednisone—ankylosing spondylitis	0.000286	0.00166	CcSEcCtD
Letrozole—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000286	0.00166	CcSEcCtD
Letrozole—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000286	0.00166	CcSEcCtD
Letrozole—Discomfort—Triamcinolone—ankylosing spondylitis	0.000285	0.00165	CcSEcCtD
Letrozole—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000285	0.00165	CcSEcCtD
Letrozole—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000283	0.00164	CcSEcCtD
Letrozole—Angioedema—Dexamethasone—ankylosing spondylitis	0.000281	0.00163	CcSEcCtD
Letrozole—Angioedema—Betamethasone—ankylosing spondylitis	0.000281	0.00163	CcSEcCtD
Letrozole—Stomatitis—Methotrexate—ankylosing spondylitis	0.00028	0.00162	CcSEcCtD
Letrozole—Angiopathy—Prednisone—ankylosing spondylitis	0.00028	0.00162	CcSEcCtD
Letrozole—Malaise—Dexamethasone—ankylosing spondylitis	0.000278	0.00161	CcSEcCtD
Letrozole—Malaise—Betamethasone—ankylosing spondylitis	0.000278	0.00161	CcSEcCtD
Letrozole—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000277	0.00161	CcSEcCtD
Letrozole—Oedema—Triamcinolone—ankylosing spondylitis	0.000277	0.00161	CcSEcCtD
Letrozole—Vertigo—Dexamethasone—ankylosing spondylitis	0.000277	0.0016	CcSEcCtD
Letrozole—Vertigo—Betamethasone—ankylosing spondylitis	0.000277	0.0016	CcSEcCtD
Letrozole—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000276	0.0016	CcSEcCtD
Letrozole—Infection—Triamcinolone—ankylosing spondylitis	0.000275	0.00159	CcSEcCtD
Letrozole—Sweating—Methotrexate—ankylosing spondylitis	0.000275	0.00159	CcSEcCtD
Letrozole—Infection—Methylprednisolone—ankylosing spondylitis	0.000275	0.00159	CcSEcCtD
Letrozole—Insomnia—Prednisolone—ankylosing spondylitis	0.000272	0.00158	CcSEcCtD
Letrozole—Alopecia—Prednisone—ankylosing spondylitis	0.000272	0.00158	CcSEcCtD
Letrozole—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000271	0.00157	CcSEcCtD
Letrozole—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000271	0.00157	CcSEcCtD
Letrozole—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00027	0.00157	CcSEcCtD
Letrozole—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00027	0.00157	CcSEcCtD
Letrozole—Mental disorder—Prednisone—ankylosing spondylitis	0.00027	0.00156	CcSEcCtD
Letrozole—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00027	0.00156	CcSEcCtD
Letrozole—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000268	0.00156	CcSEcCtD
Letrozole—Malnutrition—Prednisone—ankylosing spondylitis	0.000268	0.00155	CcSEcCtD
Letrozole—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000268	0.00155	CcSEcCtD
Letrozole—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000267	0.00155	CcSEcCtD
Letrozole—Hypertension—Betamethasone—ankylosing spondylitis	0.000266	0.00154	CcSEcCtD
Letrozole—Hypertension—Dexamethasone—ankylosing spondylitis	0.000266	0.00154	CcSEcCtD
Letrozole—Myalgia—Betamethasone—ankylosing spondylitis	0.000262	0.00152	CcSEcCtD
Letrozole—Myalgia—Dexamethasone—ankylosing spondylitis	0.000262	0.00152	CcSEcCtD
Letrozole—Anxiety—Dexamethasone—ankylosing spondylitis	0.000261	0.00151	CcSEcCtD
Letrozole—Anxiety—Betamethasone—ankylosing spondylitis	0.000261	0.00151	CcSEcCtD
Letrozole—Discomfort—Dexamethasone—ankylosing spondylitis	0.000259	0.0015	CcSEcCtD
Letrozole—Discomfort—Betamethasone—ankylosing spondylitis	0.000259	0.0015	CcSEcCtD
Letrozole—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000259	0.0015	CcSEcCtD
Letrozole—Pain—Prednisolone—ankylosing spondylitis	0.000258	0.00149	CcSEcCtD
Letrozole—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000257	0.00149	CcSEcCtD
Letrozole—Hepatitis—Methotrexate—ankylosing spondylitis	0.000257	0.00149	CcSEcCtD
Letrozole—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000254	0.00147	CcSEcCtD
Letrozole—Vision blurred—Prednisone—ankylosing spondylitis	0.000253	0.00146	CcSEcCtD
Letrozole—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000252	0.00146	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000252	0.00146	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000252	0.00146	CcSEcCtD
Letrozole—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000251	0.00146	CcSEcCtD
Letrozole—Oedema—Dexamethasone—ankylosing spondylitis	0.000251	0.00146	CcSEcCtD
Letrozole—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000251	0.00146	CcSEcCtD
Letrozole—Oedema—Betamethasone—ankylosing spondylitis	0.000251	0.00146	CcSEcCtD
Letrozole—Insomnia—Triamcinolone—ankylosing spondylitis	0.000251	0.00145	CcSEcCtD
Letrozole—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00025	0.00145	CcSEcCtD
Letrozole—Infection—Betamethasone—ankylosing spondylitis	0.00025	0.00145	CcSEcCtD
Letrozole—Infection—Dexamethasone—ankylosing spondylitis	0.00025	0.00145	CcSEcCtD
Letrozole—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000249	0.00144	CcSEcCtD
Letrozole—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000249	0.00144	CcSEcCtD
Letrozole—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000248	0.00144	CcSEcCtD
Letrozole—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000248	0.00144	CcSEcCtD
Letrozole—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000247	0.00143	CcSEcCtD
Letrozole—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000246	0.00143	CcSEcCtD
Letrozole—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000246	0.00143	CcSEcCtD
Letrozole—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000245	0.00142	CcSEcCtD
Letrozole—Tachycardia—Betamethasone—ankylosing spondylitis	0.000245	0.00142	CcSEcCtD
Letrozole—Angioedema—Prednisone—ankylosing spondylitis	0.000245	0.00142	CcSEcCtD
Letrozole—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000244	0.00141	CcSEcCtD
Letrozole—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000243	0.00141	CcSEcCtD
Letrozole—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000243	0.00141	CcSEcCtD
Letrozole—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000243	0.00141	CcSEcCtD
Letrozole—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000243	0.00141	CcSEcCtD
Letrozole—Malaise—Prednisone—ankylosing spondylitis	0.000242	0.0014	CcSEcCtD
Letrozole—Vertigo—Prednisone—ankylosing spondylitis	0.000241	0.0014	CcSEcCtD
Letrozole—Eye disorder—Methotrexate—ankylosing spondylitis	0.000241	0.00139	CcSEcCtD
Letrozole—Anorexia—Betamethasone—ankylosing spondylitis	0.00024	0.00139	CcSEcCtD
Letrozole—Anorexia—Dexamethasone—ankylosing spondylitis	0.00024	0.00139	CcSEcCtD
Letrozole—Urticaria—Prednisolone—ankylosing spondylitis	0.000239	0.00139	CcSEcCtD
Letrozole—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000239	0.00138	CcSEcCtD
Letrozole—Fatigue—Triamcinolone—ankylosing spondylitis	0.000239	0.00138	CcSEcCtD
Letrozole—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000238	0.00138	CcSEcCtD
Letrozole—Pain—Triamcinolone—ankylosing spondylitis	0.000237	0.00137	CcSEcCtD
Letrozole—Angiopathy—Methotrexate—ankylosing spondylitis	0.000234	0.00135	CcSEcCtD
Letrozole—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000232	0.00134	CcSEcCtD
Letrozole—Hypertension—Prednisone—ankylosing spondylitis	0.000232	0.00134	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000229	0.00133	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000229	0.00133	CcSEcCtD
Letrozole—Myalgia—Prednisone—ankylosing spondylitis	0.000228	0.00132	CcSEcCtD
Letrozole—Arthralgia—Prednisone—ankylosing spondylitis	0.000228	0.00132	CcSEcCtD
Letrozole—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000228	0.00132	CcSEcCtD
Letrozole—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000228	0.00132	CcSEcCtD
Letrozole—Anxiety—Prednisone—ankylosing spondylitis	0.000228	0.00132	CcSEcCtD
Letrozole—Alopecia—Methotrexate—ankylosing spondylitis	0.000228	0.00132	CcSEcCtD
Letrozole—Insomnia—Dexamethasone—ankylosing spondylitis	0.000227	0.00132	CcSEcCtD
Letrozole—Insomnia—Betamethasone—ankylosing spondylitis	0.000227	0.00132	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000227	0.00131	CcSEcCtD
Letrozole—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000226	0.00131	CcSEcCtD
Letrozole—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000226	0.00131	CcSEcCtD
Letrozole—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000226	0.00131	CcSEcCtD
Letrozole—Discomfort—Prednisone—ankylosing spondylitis	0.000226	0.00131	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—ankylosing spondylitis	0.000226	0.00131	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—ankylosing spondylitis	0.000224	0.0013	CcSEcCtD
Letrozole—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000221	0.00128	CcSEcCtD
Letrozole—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000221	0.00128	CcSEcCtD
Letrozole—Urticaria—Triamcinolone—ankylosing spondylitis	0.00022	0.00128	CcSEcCtD
Letrozole—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00022	0.00127	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000219	0.00127	CcSEcCtD
Letrozole—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000219	0.00127	CcSEcCtD
Letrozole—Oedema—Prednisone—ankylosing spondylitis	0.000219	0.00127	CcSEcCtD
Letrozole—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000219	0.00127	CcSEcCtD
Letrozole—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000218	0.00127	CcSEcCtD
Letrozole—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000218	0.00127	CcSEcCtD
Letrozole—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000218	0.00127	CcSEcCtD
Letrozole—Infection—Prednisone—ankylosing spondylitis	0.000217	0.00126	CcSEcCtD
Letrozole—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000217	0.00126	CcSEcCtD
Letrozole—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000217	0.00126	CcSEcCtD
Letrozole—Back pain—Methotrexate—ankylosing spondylitis	0.000217	0.00126	CcSEcCtD
Letrozole—Fatigue—Betamethasone—ankylosing spondylitis	0.000217	0.00126	CcSEcCtD
Letrozole—Fatigue—Dexamethasone—ankylosing spondylitis	0.000217	0.00126	CcSEcCtD
Letrozole—Pain—Betamethasone—ankylosing spondylitis	0.000215	0.00125	CcSEcCtD
Letrozole—Pain—Dexamethasone—ankylosing spondylitis	0.000215	0.00125	CcSEcCtD
Letrozole—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000215	0.00124	CcSEcCtD
Letrozole—Tachycardia—Prednisone—ankylosing spondylitis	0.000214	0.00124	CcSEcCtD
Letrozole—Skin disorder—Prednisone—ankylosing spondylitis	0.000213	0.00123	CcSEcCtD
Letrozole—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000212	0.00123	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—ankylosing spondylitis	0.000211	0.00122	CcSEcCtD
Letrozole—Anorexia—Prednisone—ankylosing spondylitis	0.000209	0.00121	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000208	0.00121	CcSEcCtD
Letrozole—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000207	0.0012	CcSEcCtD
Letrozole—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000207	0.0012	CcSEcCtD
Letrozole—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000206	0.00119	CcSEcCtD
Letrozole—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000206	0.00119	CcSEcCtD
Letrozole—Malaise—Methotrexate—ankylosing spondylitis	0.000202	0.00117	CcSEcCtD
Letrozole—Vertigo—Methotrexate—ankylosing spondylitis	0.000201	0.00117	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—ankylosing spondylitis	0.000201	0.00116	CcSEcCtD
Letrozole—Urticaria—Betamethasone—ankylosing spondylitis	0.0002	0.00116	CcSEcCtD
Letrozole—Urticaria—Dexamethasone—ankylosing spondylitis	0.0002	0.00116	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000199	0.00116	CcSEcCtD
Letrozole—Dizziness—Prednisolone—ankylosing spondylitis	0.000199	0.00115	CcSEcCtD
Letrozole—Asthenia—Triamcinolone—ankylosing spondylitis	0.000199	0.00115	CcSEcCtD
Letrozole—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000199	0.00115	CcSEcCtD
Letrozole—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000199	0.00115	CcSEcCtD
Letrozole—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000199	0.00115	CcSEcCtD
Letrozole—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000199	0.00115	CcSEcCtD
Letrozole—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000198	0.00115	CcSEcCtD
Letrozole—Insomnia—Prednisone—ankylosing spondylitis	0.000198	0.00115	CcSEcCtD
Letrozole—Paraesthesia—Prednisone—ankylosing spondylitis	0.000197	0.00114	CcSEcCtD
Letrozole—Pruritus—Triamcinolone—ankylosing spondylitis	0.000196	0.00114	CcSEcCtD
Letrozole—Cough—Methotrexate—ankylosing spondylitis	0.000196	0.00113	CcSEcCtD
Letrozole—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000196	0.00113	CcSEcCtD
Letrozole—Dyspepsia—Prednisone—ankylosing spondylitis	0.000193	0.00112	CcSEcCtD
Letrozole—Chest pain—Methotrexate—ankylosing spondylitis	0.000191	0.00111	CcSEcCtD
Letrozole—Myalgia—Methotrexate—ankylosing spondylitis	0.000191	0.00111	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—ankylosing spondylitis	0.000191	0.00111	CcSEcCtD
Letrozole—Decreased appetite—Prednisone—ankylosing spondylitis	0.00019	0.0011	CcSEcCtD
Letrozole—Rash—Prednisolone—ankylosing spondylitis	0.00019	0.0011	CcSEcCtD
Letrozole—Dermatitis—Prednisolone—ankylosing spondylitis	0.00019	0.0011	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00019	0.0011	CcSEcCtD
Letrozole—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000189	0.0011	CcSEcCtD
Letrozole—Fatigue—Prednisone—ankylosing spondylitis	0.000189	0.00109	CcSEcCtD
Letrozole—Headache—Prednisolone—ankylosing spondylitis	0.000189	0.00109	CcSEcCtD
Letrozole—Discomfort—Methotrexate—ankylosing spondylitis	0.000189	0.00109	CcSEcCtD
Letrozole—Constipation—Prednisone—ankylosing spondylitis	0.000187	0.00108	CcSEcCtD
Letrozole—Dizziness—Triamcinolone—ankylosing spondylitis	0.000183	0.00106	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000183	0.00106	CcSEcCtD
Letrozole—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000183	0.00106	CcSEcCtD
Letrozole—Infection—Methotrexate—ankylosing spondylitis	0.000182	0.00105	CcSEcCtD
Letrozole—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00018	0.00105	CcSEcCtD
Letrozole—Asthenia—Dexamethasone—ankylosing spondylitis	0.00018	0.00104	CcSEcCtD
Letrozole—Asthenia—Betamethasone—ankylosing spondylitis	0.00018	0.00104	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000179	0.00104	CcSEcCtD
Letrozole—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000179	0.00104	CcSEcCtD
Letrozole—Nausea—Prednisolone—ankylosing spondylitis	0.000179	0.00104	CcSEcCtD
Letrozole—Pruritus—Dexamethasone—ankylosing spondylitis	0.000178	0.00103	CcSEcCtD
Letrozole—Pruritus—Betamethasone—ankylosing spondylitis	0.000178	0.00103	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—ankylosing spondylitis	0.000178	0.00103	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000177	0.00102	CcSEcCtD
Letrozole—Vomiting—Triamcinolone—ankylosing spondylitis	0.000176	0.00102	CcSEcCtD
Letrozole—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000176	0.00102	CcSEcCtD
Letrozole—Rash—Triamcinolone—ankylosing spondylitis	0.000175	0.00101	CcSEcCtD
Letrozole—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000174	0.00101	CcSEcCtD
Letrozole—Anorexia—Methotrexate—ankylosing spondylitis	0.000174	0.00101	CcSEcCtD
Letrozole—Rash—Methylprednisolone—ankylosing spondylitis	0.000174	0.00101	CcSEcCtD
Letrozole—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000174	0.00101	CcSEcCtD
Letrozole—Urticaria—Prednisone—ankylosing spondylitis	0.000174	0.00101	CcSEcCtD
Letrozole—Headache—Triamcinolone—ankylosing spondylitis	0.000174	0.00101	CcSEcCtD
Letrozole—Headache—Methylprednisolone—ankylosing spondylitis	0.000173	0.001	CcSEcCtD
Letrozole—Body temperature increased—Prednisone—ankylosing spondylitis	0.000173	0.001	CcSEcCtD
Letrozole—Abdominal pain—Prednisone—ankylosing spondylitis	0.000173	0.001	CcSEcCtD
Letrozole—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000172	0.000997	CcSEcCtD
Letrozole—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000172	0.000997	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000167	0.000966	CcSEcCtD
Letrozole—Dizziness—Dexamethasone—ankylosing spondylitis	0.000166	0.000963	CcSEcCtD
Letrozole—Dizziness—Betamethasone—ankylosing spondylitis	0.000166	0.000963	CcSEcCtD
Letrozole—Insomnia—Methotrexate—ankylosing spondylitis	0.000165	0.000959	CcSEcCtD
Letrozole—Nausea—Triamcinolone—ankylosing spondylitis	0.000165	0.000953	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000164	0.000952	CcSEcCtD
Letrozole—Nausea—Methylprednisolone—ankylosing spondylitis	0.000164	0.000951	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000163	0.000945	CcSEcCtD
Letrozole—Somnolence—Methotrexate—ankylosing spondylitis	0.000163	0.000942	CcSEcCtD
Letrozole—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000161	0.000933	CcSEcCtD
Letrozole—Vomiting—Betamethasone—ankylosing spondylitis	0.00016	0.000926	CcSEcCtD
Letrozole—Vomiting—Dexamethasone—ankylosing spondylitis	0.00016	0.000926	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000159	0.000921	CcSEcCtD
Letrozole—Rash—Dexamethasone—ankylosing spondylitis	0.000158	0.000918	CcSEcCtD
Letrozole—Rash—Betamethasone—ankylosing spondylitis	0.000158	0.000918	CcSEcCtD
Letrozole—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000158	0.000917	CcSEcCtD
Letrozole—Dermatitis—Betamethasone—ankylosing spondylitis	0.000158	0.000917	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000158	0.000915	CcSEcCtD
Letrozole—Fatigue—Methotrexate—ankylosing spondylitis	0.000158	0.000914	CcSEcCtD
Letrozole—Headache—Dexamethasone—ankylosing spondylitis	0.000157	0.000912	CcSEcCtD
Letrozole—Headache—Betamethasone—ankylosing spondylitis	0.000157	0.000912	CcSEcCtD
Letrozole—Asthenia—Prednisone—ankylosing spondylitis	0.000157	0.00091	CcSEcCtD
Letrozole—Pain—Methotrexate—ankylosing spondylitis	0.000156	0.000906	CcSEcCtD
Letrozole—Pruritus—Prednisone—ankylosing spondylitis	0.000155	0.000897	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000151	0.000874	CcSEcCtD
Letrozole—Diarrhoea—Prednisone—ankylosing spondylitis	0.00015	0.000868	CcSEcCtD
Letrozole—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00015	0.000867	CcSEcCtD
Letrozole—Nausea—Betamethasone—ankylosing spondylitis	0.000149	0.000865	CcSEcCtD
Letrozole—Nausea—Dexamethasone—ankylosing spondylitis	0.000149	0.000865	CcSEcCtD
Letrozole—Urticaria—Methotrexate—ankylosing spondylitis	0.000145	0.000842	CcSEcCtD
Letrozole—Dizziness—Prednisone—ankylosing spondylitis	0.000145	0.000839	CcSEcCtD
Letrozole—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000145	0.000838	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000145	0.000838	CcSEcCtD
Letrozole—Vomiting—Prednisone—ankylosing spondylitis	0.000139	0.000806	CcSEcCtD
Letrozole—Rash—Prednisone—ankylosing spondylitis	0.000138	0.0008	CcSEcCtD
Letrozole—Dermatitis—Prednisone—ankylosing spondylitis	0.000138	0.000799	CcSEcCtD
Letrozole—Headache—Prednisone—ankylosing spondylitis	0.000137	0.000795	CcSEcCtD
Letrozole—Asthenia—Methotrexate—ankylosing spondylitis	0.000131	0.000761	CcSEcCtD
Letrozole—Nausea—Prednisone—ankylosing spondylitis	0.00013	0.000753	CcSEcCtD
Letrozole—Pruritus—Methotrexate—ankylosing spondylitis	0.000129	0.00075	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000125	0.000725	CcSEcCtD
Letrozole—Dizziness—Methotrexate—ankylosing spondylitis	0.000121	0.000701	CcSEcCtD
Letrozole—Vomiting—Methotrexate—ankylosing spondylitis	0.000116	0.000674	CcSEcCtD
Letrozole—Rash—Methotrexate—ankylosing spondylitis	0.000115	0.000668	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—ankylosing spondylitis	0.000115	0.000668	CcSEcCtD
Letrozole—Headache—Methotrexate—ankylosing spondylitis	0.000115	0.000664	CcSEcCtD
Letrozole—Nausea—Methotrexate—ankylosing spondylitis	0.000109	0.00063	CcSEcCtD
